Home > Listed Companies Info. > Main Board Companies

:::

:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

Code:

Industry:

Local/Foreign Company:

6733 BioGend

中文

Company Profile

Chairman

CEO

Spokesperson

Tel

Address

Date of Listing (Regular)

Te Li Chen

Byron Chao

02-26558366

4F, No.3-2, Yuang St.Nangang DistrictTaipei City, Taiwan, R.O.C.

2021/01/28

Industry

Main Business

Biotechnology and Medical Care

BioGend Therapeutics was established in July 2016 with a noble vision to develop regenerative bio-orthopedic medicine to advance the clinical science of maintaining healthy joints in the skeletal system. We are committed to developing innovative bio-orthopedic devices and treatment methods that can fulfill unmet clinical needs benefiting patients worldwide. The project management teams at BioGend Therapeutics are led by seasoned product development managers with team members from different functional areas. Each development project is carefully planned to follow the phase-gate process for effective and efficient execution. For highly regulated biomedical devices, the expertise in regulatory affairs and pre-clinical and clinical development is essential in order to gain regulatory approval and to realize the potential value of innovative bio-technologies.

Shr. Vol.	Highest	Lowest	Closed	Change	Transaction	TurnOver(%)	long margin balance (1,000shr.)	Short margin balance (1,000shr.)
Market Information ( 2024/04/18 )
123.274	37.15	36.60	37.10	0.05	78		N/A	N/A
Trading method	Fun purchase price or securities pneeded on T day	Announcement of Irregularity (2024/04/18)	TPEx measures adopted (2024/04/18)		With warrants	Can be shorted or margined?	Detail
Normal	N	N	N		N	N	Today	History

Financial Reports
Cash Flows	Items
	Items	Amount (NT$ thousand)
	Cash flows from operating activities
	Cash flows from investing activities
	Cash flows from financing activities
Balance Sheets	Current assets
	Non-current assets
	Total assets
	Current liabilities
	Non-current liabilities
	Total liabilities
	Share capital
	Capital surplus
	Retained earnings
	Other equity interest
	Treasury shares
	Total equity attributable to owners of parent
	Non-controlling interests
	Total equity
	Book Value per share(NT$)
Comprehensive Income	Operating revenue
	Operating costs
	Gross profit from operations
	Operating expenses
	Net other income (expenses)
	Net operating income
	Non-operating income and expenses
	Profit before tax
	Tax expense
	Profit from continuing operations
	Profit from discontinued operations
	Profit
	Other comprehensive income
	Comprehensive income
	Basic earnings per share

Auditor's report on latest financial statements： auditor's report：

More detail:MOPS。

Foreign issuers’ information is disclosed in consolidated statements.

TOP

TPEx

Listed Companies

General Stock Board Listed Company Profile